Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.

@article{Hunt2001BenefitsOP,
  title={Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.},
  author={Darla Hunt and Phil Young and John Simes and Waqar Hague and Sarika Mann and Dwain A. Owensby and Geoffrey Lane and Andrew Tonkin},
  journal={Annals of internal medicine},
  year={2001},
  volume={134 10},
  pages={931-40}
}
Coronary heart disease is the major cause of death in middle-aged and older persons (1-3). Blood cholesterol level is a major risk factor for coronary heart disease, and although it was previously thought to be of less prognostic importance in older people (4, 5), it is now accepted as a major risk factor in that population (6-8). Recent studies in patients with coronary heart disease have shown that decreasing blood cholesterol levels with 3-hydroxy-3-methylglutaryl coenzyme A reductase… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 80 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Similar Papers

Loading similar papers…